Narjust Florez is one of the co-chairs at this year’s WCLC – Florez Lab
The Florez Lab shared on X:
“Thrilled to share that Dr. Narjust Florez is one of the co-chairs at this year’s WCLC! It’s going to be an exciting and incredibly educational event. Get ready to see all the innovative work driving the fight against lung cancer!”
Source: The Florez Lab/X
For more posts by The Florez Lab, visit oncodaily.com
Narjust Florez is the Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist at the Dana-Farber Brigham Cancer Center. She is the principal investigator of the Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study, the largest study to date evaluating sexual dysfunction in women with lung cancer. In addition, Dr. Florez founded the Florez Lab in 2019. The laboratory focuses on lung cancer, social justice issues in medicine, and medical education.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023